Order Article Reprints

Teng W, Jeng W-J, Yang H-I, Chen W-T, Hsieh Y-C, Huang C-H, Lin C-C, Lin C-Y, Lin S-M, Sheen I-S. Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma. Cancers. 2020; 12(1):23. https://doi.org/10.3390/cancers12010023

Teng, Wei, Wen-Juei Jeng, Hwai-I Yang, Wei-Ting Chen, Yi-Chung Hsieh, Chien-Hao Huang, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin, and I-Shyan Sheen. 2020. "Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma" Cancers 12, no. 1: 23. https://doi.org/10.3390/cancers12010023

Teng, W., Jeng, W.-J., Yang, H.-I., Chen, W.-T., Hsieh, Y.-C., Huang, C.-H., Lin, C.-C., Lin, C.-Y., Lin, S.-M., & Sheen, I.-S. (2020). Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma. Cancers, 12(1), 23. https://doi.org/10.3390/cancers12010023